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Abstract:  Circadian disruptions are common in modern society, and there is an urgent need for effective treatment   
strategies. According to standard diagnostic criteria, most adolescents showing both insomnia and daytime sleepiness are 
diagnosed as having behavioral-induced sleep efficiency syndrome resulting from insomnia due to inadequate sleep   
hygiene. However, a simple intervention of adequate sleep hygiene often fails to treat them. As a solution to this clinical 
problem, the present review first overviews the basic neurochemical and neuropharmachological aspects of sleep and  
circadian rhythm regulation, then explains several circadian disruptions from similar viewpoints, and finally introduces 
the clinical notion of asynchronization. Asynchronization is designated to explain the pathophysiology/pathogenesis of 
exhibition of both insomnia and hypersomnia in adolescents, which comprises disturbances in various aspects of biologi-
cal rhythms. The major triggers for asynchronization are considered to be a combination of light exposure during the 
night, which disturbs the biological clock and decreases melatonin secretion, as well as a lack of light exposure in the 
morning, which prohibits normal synchronization of the biological clock to the 24-hour cycle of the earth and decreases 
the activity of serotonin. In the chronic phase of asynchronization, involvement of both wake- and sleep-promoting   
systems is suggested. Both conventional and alternative therapeutic approaches for potential treatment of asynchronization 
are suggested. 
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1. INTRODUCTION 
  People whose circadian rhythms are out of phase with 
their daily schedule are said to have ‘social jet lag’ [1, 2]. 
Circadian rhythm problems are common in modern society, 
and there is an urgent need for effective treatment strategies. 
In Japan, approximately one quarter of junior high school 
students suffer from insomnia, while more than half of the 
students complain of daytime sleepiness [3]. Among adoles-
cents in China, 16.1% had insomnia and 17.9% had daytime 
sleepiness [4]. In the United States, 22.8 % of adolescents 
reported insomnia and 34.7 % had daytime fatigue or sleepi-
ness [5]. Among adolescents in Spain, the prevalence of in-
somnia was found to be 9.9% and that of daytime sleepiness, 
53.0% [6]. These subjects had delayed bedtimes with com-
plaint of insomnia. Delayed bedtimes result in sleep loss [7], 
producing daytime sleepiness. Daytime sleepiness could 
cause nocturnal insomnia. The subjects are living with dis-
turbed habits such as delayed wake-up times, delayed bed-
times, and an irregular lifestyle. Speculatively, these subjects 
may be suffering from behavioral-induced sleep efficiency 
syndrome, presumably resulting from insomnia due to in-
adequate sleep hygiene. In fact, frequent complaints of these 
subjects introduced in my former review (Table 1) [3] were 
compatible with associated features of behavioral-induced 
sleep-deficient syndrome [8], most likely due to inadequate 
sleep hygiene with low-level physical activity (sedentary   
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behavior), excessive media exposure, and excessive caffeine 
use [9]. If this were the case, these symptoms should be ame-
liorated following adequate sleep hygiene (Table 2). How-
ever, such therapeutic approaches often fail. Unknown fac-
tors or neuronal mechanisms may be preventing recovery. 
Asynchronization was proposed to solve this clinical prob-
lem [3], taking a basic concept of singularity (suppression of 
circadian rhythm) [10] into consideration. The present re-
view first provides an overview of the basic neurochemical 
and neuropharmachological aspects of sleep and circadian 
rhythm regulation, then explains several circadian disrup-
tions from similar viewpoints, and finally introduces the 
clinical notion of asynchronization. 
2. BASIC ASPECTS OF SLEEP AND CIRCADIAN 
RHYTHM REGULATION 
2.1. Basic Aspects of Sleep 
  Orexin, neuropeptide S (NPS), and histamine are known 
as representative neurotransmitters that participate in pro-
moting arousal. Orexin-A levels in lumbar cerebrospinal 
fluid have been reported to be slightly higher at 5 AM than at 
5 PM [11], whereas no report on diurnal fluctuation of NPS 
is available. Interestingly, NPS produces anxiolytic-like ef-
fects as well [12, 13]. Diurnal variation in cerebrospinal fluid 
levels of tele-methylhistamine (t-MH), the main histamine 
metabolite, was detected in children; the mean t-MH concen-
tration was significantly higher during the daytime than dur-
ing nighttime [14]. Compatible with this observation, mice 
histamine neurons in the tuberomammillary nuclei of the 
posterior hypothalamus were found to be active only during 
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at the different waking states, and is lowest during quiet 
waking, moderate during active waking, and highest during 
attentive waking. Their activity is likely to be related to a 
high level of vigilance. Histamine-1-receptor (H1R) agonists 
are known to be implicated in inducing arousal and wakeful-
ness in humans, and in H1R knockout mice, the motivational 
effects of novelty are reported to be diminished [16].  
Table 2.  Requirements for Adequate Sleep Hygiene 
Issues Examples 
Morning light exposure   
Physical activities   
Avoidance of nocturnal light exposure   
Regular meals   
Avoidance of inappropriate substances  Caffeine, nicotine 
Suitable environment  Illumination, temperature, 
humidity, noise 
  The histaminergic system recently has been found to be 
affected by adenosine. Endogenous adenosine in the tubero-
mammillary nucleus, where histaminergic neurons exist, 
suppresses the histaminergic system via adenosine A1 recep-
tors to promote non-rapid eye movement sleep [17]. Adeno-
sine was also reported to mediate the sleep-promoting effect 
of prostaglandin D(2) through adenosine A2A receptors [18]. 
Caffeine is known to induce wakefulness by binding to 
adenosine A2A receptors as an antagonist [18], whereas the 
mechanism of action of modafinil, the antinarcoleptic, is still 
unknown [19]. In addition to adenosine [20], many sleep-
promoting systems or substances have been reported. The 
ventrolateral preoptic area [21] and the median preoptic nu-
cleus [22] are widely accepted areas to induce and/or main-
tain sleep. The discovery of the delta-sleep-inducing peptide 
[23] facilitated the progress of this research area. The studies 
on the sleep-modulating effects of cytokines [24] followed 
the discovery of the sleep-promoting effects of muramyl 
peptides [25]. Prostaglandin D(2) was most likely the en-
dogenous sleep substance described by Ishimori [26] and 
Piéron [27] about 100 years ago [28]. In addition, uridine 
[29], oxidative glutathione [30], organic bromide compound 
[31], and fatty acid amide hydrolase [32] are reported to have 
sleep-promoting effects. 
  On the molecular level, several alterations associated 
with sleep have been reported. The number of synaptic ter-
minals was reduced during sleep, but this decline was pre-
vented by sleep deprivation [33] In the Drosophila brain, 
protein levels of key components of central synapses were 
found to be higher after waking and lower after sleep [34]. In 
humans, with regard to behavior, sleep loss has been demon-
strated to exert a negative effect on daytime functions [35-
37], general well being [38], metabolic and endocrine func-
tion [39, 40], body weight [41], viral infections [42], and 
psychomotor vigilance, including mood [43]. However, the 
required sleep duration of an individual person is difficult to 
determine because the need for sleep is variable and depends 
on many factors [44]. In addition, regardless of sleep dura-
tion, problematic behaviors are known to be associated with 
the aforementioned disturbances in daily habits [45-57]. 
  The duration of sleep is longer in the winter than in the 
summer [58], and the adolescents in East Germany have ear-
Table 1.  Frequent Complaints of Youngsters in Japan* 
Elementary School Students    Junior High School Students  Boys/Girls 
Persistent need to yawn  62%  Desire to sleep  73.8%/80.8% 
Desire to sleep  58%  Persistent need to yawn  43.6%/69.1% 
Desire to lie down  47%  Desire to lie down  43.2%/47.2% 
Eyestrain 33%  Eyestrain  40.7%/44.7% 
Difficulty in sitting straight  29%  Difficulty with memorization   35.2%/33.6% 
Difficulty with memorization  28%  Neck stiffness  29.3%/35.1% 
Irritation 27%  Lumbago  26.5%/23.2% 
Neck stiffness  26%  Low activity  21.3%/28.0% 
Low activity  25%  Hypersensitivity  20.0%/27.0% 
Difficulty in concentrating  25%  Difficulty in concentrating  21.0%/23.8% 
Hypersensitivity 24%  Irritation  20.5%/24.2% 
Thirst 21%     
Making many mistakes  20%     
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lier waking times and bedtimes than those in West Germany 
[59]. Human sleep behavior is supposed to be regulated by 
sunlight, although unconsciously. 
2.2. Basic Aspects of Circadian Rhythm 
  In mammals, intrinsically photosensitive retinal ganglion 
cells (ipRGCs) exhibit light responses independent of rod 
and cone signaling [60, 61]. These cells express the pho-
topigment melanopsin, project directly to the suprachias-
matic nucleus (SCN) of the hypothalamus (the site of the 
circadian clock), and thereby contribute to non-image-
forming responses to light. Light stimuli activate N-methyl-
d-Aspartate (NMDA)/non-NMDA receptors of the SCN 
[62]. Signals from the SCN regulate various circadian 
rhythms including feeding, locomotion, sleep-wake alterna-
tion, corticosterone secretion [63], and the autonomic nerv-
ous system [64]. Typically, the endogenous period of the 
circadian clock in humans is longer than 24 hours, although 
the racial differences in the human endogenous circadian 
period have been reported [65]. It is through morning expo-
sure to sunlight that people become accustomed to the 24-
hour cycle [66]. Conversely, light exposure at night delays 
the circadian clock phase [66] or disrupts its function [67, 
68]. Thus, nocturnal light exposure has unfavorable effects 
on the biological clock. Non-photic cues such as physical 
activity [69], social factors [70], and eating times [71] also 
serve to synchronize the circadian system to a 24-hour day. 
Of these, the mechanism of food-anticipatory rhythms has 
recently been clarified [71]: The dorsomedial hypothalamic 
nucleus was determined to be a putative food-entrainable 
circadian pacemaker in mice, and oscillation of this pace-
maker was found to persist for at least two days, even when 
mice received no food during the expected feeding period 
following establishment of food-entrained behavioral 
rhythms. 
  In the absence of time cues, daily rhythms become al-
tered and develop their own rhythm. After living under such 
unusual conditions for a considerable period of time, recip-
rocal phase interactions within circadian rhythms such as 
sleep-wakefulness and temperature are disturbed [72]. In 
general, most people wake in the morning when their body 
temperature begins to rise from its lowest level and, con-
versely, fall asleep at night when their body temperature be-
gins to decline from its highest level. However, once this 
reciprocal interaction is impaired, the phase relationship be-
tween body temperature and sleep-wakefulness circadian 
rhythms is disrupted [72]. This disruption is termed ‘cir-
cadian desynchronization’, and produces various physical 
and mood disturbances such as disturbed nighttime sleep, 
impaired daytime alertness and performance, disorientation, 
gastrointestinal problems, loss of appetite, inappropriate tim-
ing of defecation, and excessive need to urinate during the 
night [73-75]. Similar complaints and mood alterations have 
been observed in patients with jet lag [76] or seasonal affec-
tive disorder [77], and in astronauts [78].  
  ‘Larks’ and ‘owls’ are respective terminologies for peo-
ple who wake up early in the morning and are ready for sleep 
early in the evening, and those who wake up late in the 
morning and feel less sleepiness even late in the evening. A 
self-assessment questionnaire was used to determine if an 
individual was a morning- or an evening-type person (chro-
notypes: larks or owls) [79]. Endogenous phasing of the cir-
cadian biological clock in morning-type individuals varies 
from that of evening-type individuals [80]; the latter experi-
ence a temperature rise later in the morning and later waking 
times [81]. Moreover, individuals who are alert in the morn-
ing experience an earlier circadian rhythm temperature peak 
than individuals who are alert in the evening [82]. Further-
more, it was suggested that evening-type individuals suffer 
from circadian desynchronization [74, 75].  
  Interestingly, it was previously demonstrated that kidney 
cells followed a 24.5-hour clock, whereas corneal cells ran at 
approximately 21.5 hours [83], suggesting that peripheral 
clocks may work in different circadian cycles. The SCN 
might serve as a reference point for the peripheral clocks, 
and the SCN and the peripheral clocks can be considered to 
work under unstable synchrony. The loss of synchrony be-
tween body tissues could underlie some of the health prob-
lems seen in circadian-rhythm disorders and shift workers 
[1]. In a recent study examining the molecular circadian 
rhythms of 11 larks and 17 owls, as assessed from the ex-
pression of brain and muscle Arnt-like protein-1 (Bmal1) in 
their skin cells, cells from larks showed shorter circadian 
period length than those from owls [84]. Bmal1 is a tran-
scription factor known to regulate circadian rhythm [85]. 
Approximately half of the larks and owls actually had ‘nor-
mal’ circadian period length, whereas the owls had skin 
clocks that were more difficult to reset than those of people 
with more typical schedules, and the larks had clocks that 
were easier to reset [84]. These studies suggest that individ-
ual differences in chronotype can result from both innate 
differences in circadian period length and in how easily a 
person’s rhythms can be synchronized to the night-day cycle. 
2.3. Melatonin 
  Melatonin regulates the circadian phase [86], acts as a 
hypnotic, and is an effective free-radical scavenger and anti-
oxidant, which directly induces gonadotropin-inhibitory 
hormone expression [87]. In addition, melatonin is consid-
ered to be involved in the inhibition of cancer development 
and growth [88]. Interestingly, bright light during the night-
time decreases melatonin secretion [89]. Melatonin immune 
staining was demonstrated in the bacterium Rhodospirillum 
rubrum, one of the oldest species of living organisms (poten-
tially 2-3.5 billion years) [90]. Bacterial melatonin might 
provide on-site protection of bacterial DNA against free-
radical attack. Melatonin is also known to exert antioxidant 
effects in the brain [91], and sleep is hypothesized to func-
tion as an antioxidant or scavenging process in the brain 
[92].  
  Melatonin promotes and synchronizes sleep by acting on 
SCN-expressing melatonin MT1 and MT2 receptors, respec-
tively. Synthesized melatonin receptor agonists exhibiting an 
increased duration of action are expected to provide signifi-
cant clinical value for treatment of insomnia patients [93]. 
The onset of melatonin secretion begins 14-16 hours after 
waking, usually around dusk [94]. Exposure to bright, mid-
day light has been shown to increase melatonin secretion 
during the night, without a circadian phase shift [95]. In a 
preliminary study of 3-year-old children, early sleepers Neurochemical and Neuropharmacological Aspects of Circadian  Current Neuropharmacology, 2011, Vol. 9, No. 2    333
tended to exhibit higher levels of urinary 6-sulfatoxymelatonin 
(6SM) (6SM/creatinine ratio), the primary melatonin me-
tabolite, compared with late sleepers [96]. Decreased mela-
tonin levels in aged zebrafish have been shown to correlate 
with altered circadian rhythms [97]. An inversion in mela-
tonin circadian rhythm secretion was also observed in 
alcoholics, not only during alcohol intake but also during 
short- and long-term withdrawal [98]; the authors concluded 
that circadian disorganization of melatonin secretion may be 
responsible for desynchronization in some alcoholic patients. 
Because melatonin regulates the circadian phase [86], altered 
melatonin secretion could disturb circadian oscillation, pro-
ducing various biological alterations. Nevertheless, in the rat, 
altered melatonin rhythm was reported to have no effect on 
circadian rhythms of locomotor activity and body tempera-
ture [99].  
  Of the synthesized ligands of melatonin receptors [100], 
agomelatine for the treatment of depression [101], ramelteon 
for the treatment of primary chronic insomnia characterized 
by difficulty with sleep onset [102], and tasimelteon for tran-
sient insomnia in circadian rhythm sleep disorders [103] are 
the three clinically important agents. Agomelatine especially 
represents a new concept for the treatment of depression 
[104]. The antidepressant activity of agomelatine does not 
depend solely on its agonistic action at melatonergic recep-
tors, but also on its antagonistic activity at type 2C serotonin 
(5-HT2C) receptors. Agomelatine also exhibits anxiolytic 
properties that bear a striking resemblance to those of selec-
tive 5-HT2C receptor antagonists. In addition, agomelatine 
rapidly regulates the sleep-wakefulness cycle without caus-
ing sedation and improves daytime condition. This com-
pound may open new aspects on the pathophysiology of de-
pression [104].  
2.4. Serotonin 
  Serotonergic activity is highest during wakefulness, de-
creases during non-rapid eye movement sleep, and almost   
ceases during rapid eye movement sleep [105]. Involvement  
of serotonin in circadian rhythm formation has recently been  
shown. Kennaway et al. showed that activation of 5-HT2C,  
similar to the effect of a light pulse, produces long-lasting  
phase shifts in melatonin rhythm and that this effect is   
blocked by 5-HT2C antagonist [106]. Serotonin is also   
summarized to advance the phase of master pacemaker   
oscillation when applied during the subjective day and to   
inhibit light-induced phase shifts during the subjective night  
[107]. 
  The serotonergic system is activated not only through   
exposure to morning light [108] but also through rhythmic  
movements, such as gait, chewing, and respiration [109]. 
Exercise-derived benefits for brain function have been dem-
onstrated at the molecular level [110], and physical activity 
has been reported to decrease the risk of Alzheimer’s disease 
[111, 112]. Physical activity is one of the key factors pro-
moting brain function in animals and humans. Serotonin is 
considered one of the important agents that mediate these 
exercise-induced effects [113]. 
  The concept of low serotonin syndrome, which com-
prises aggressiveness, impulsivity, and suicidal behavior, has 
been proposed previously [114]. In male adult vervet mon-
keys, decreased serotonergic activity was reported to be a 
disadvantage for attaining high social dominance status, 
whereas enhanced activity was advantageous [115]. Distur-
bance in the lateral orbito-prefrontal circuit induces aggres-
sive behavior and loss of sociability [116], and the seroton-
ergic system has been shown to activate this circuit [117]. 
Serotonin levels have also been shown to enhance learning 
ability [111]. Results from positron-emission tomography 
scanning and alpha-[(11)C]methyl-L-tryptophan trapping 
suggest that low serotonin synthesis in the prefrontal cortex 
lowers the threshold for suicidal behavior [118]. In humans, 
Schweighofer et al. found that an impairment in the seroton-
ergic system is linked to action choices that are less advanta-
geous in the long run [119]. Since serotonergic activity is 
profoundly affected by the sleep-wakefulness cycle [105], 
these studies raised the possibility that irregular sleep-
wakefulness rhythm disturbs emotional control, sociability, 
and also perspective because of decreased serotonergic acti-
vation. 
3. REPORTED CONDITIONS SHOWING CIR-
CADIAN DISRUPTION 
  For the trans-meridian traveler, both physical cues such 
as daylight and darkness, and social cues such as mealtimes 
and noise, encourage realignment of the circadian system. 
By contrast, for the shift worker, physical cues are resolutely 
opposed to nocturnal alignment, as are most social cues 
stemming from a day-oriented society. Therefore, circadian 
realignment of shift workers takes longer than realignment 
from jet lag [120]. A report from the World Health Organiza-
tion's International Agency for Research on Cancer con-
cluded that “shift-work that involves circadian disruption is 
probably carcinogenic to humans” [121]. Reduced activity of 
the melatonergic system is suggested to be a causative factor 
for this association [122]. In addition, a forced, extraordinary 
schedule can induce desynchronization [70]. The modern 
‘24/7’ lifestyle with wide spread use of artificial bright light 
could also produce shift work disorder or social jet lag. Fur-
thermore, a quarter of the world’s population is subjected to 
a one-hour time change twice a year (daylight saving time; 
DST) [58]. DST is now known to disturb the normal season-
ality seen in sleep timing as assessed by mid-sleep times 
[58]. In addition, at the beginning of DST (i.e., spring), the 
rates of traffic accidents [123] and myocardial infarctions 
[124] increase. DST can be described as a system that pro-
duces social jet lag in a huge number of people. 
  Altered circadian rhythms have been described in child-
hood chronic fatigue syndrome (CFS), in which the patients 
suffer from an atypical, but continuous, jet lag condition 
[125]. One third of children with CFS exhibited abnormal 
cardiovascular regulation during postural changes (or-
thostatic dysregulation), as characterized by instantaneous 
orthostatic hypotension, or postural or neural-mediated syn-
cope [126]. Compared with the control population, adult 
patients with CFS had significantly lower systolic blood 
pressure and mean arterial blood pressure as well as exag-
gerated diurnal variation [127]. People with CFS were also 
reported to demonstrate lower salivary cortisol concentra-
tions in the morning and higher salivary cortisol concentra-
tions in the evening compared with people who did not have 
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of the diurnal cortisol profile [128]. However, studies in 
adults suggest that circadian rhythm is disturbed in some 
patients with CFS. A British cohort study revealed that sed-
entary behavior during childhood increased the risk of 
CFS/myalgic encephalomyelitis, for which depression is a 
major symptom [129]. Selective serotonin reuptake inhibi-
tors, which are widely used for patients with depression, 
have been reported to be effective in treating patients with 
CFS [130], in which decreased serotonergic activity is con-
sidered to be involved. Melatonin has also been shown to be 
effective for CFS patients with delayed circadian rhythm 
[131].  
  The characteristic clinical burnout symptoms include 
excessive and persistent fatigue, emotional distress, and cog-
nitive dysfunction [132]. These symptoms are common 
among disorders such as depression and CFS [133]. Com-
pared with controls, burnout cases had similar morning sali-
vary cortisol levels and a similar awakening response, but 
lower evening cortisol, suggesting a flattening of the diurnal 
cortisol profile [134]. Subjects exhibiting burnout are re-
ported to exhibit a higher frequency of arousal during sleep 
[133]. A study of university hospital nurses revealed that 
daylight exposure for at least three hours per day resulted in 
reduced stress and greater job satisfaction, both of which 
were favorable factors for reducing burnout [135]. Because 
bright, midday light increases melatonin secretion during the 
night in elderly individuals [95], the melatonergic system 
might be involved in the pathogenesis of burnout. A possible 
involvement of the serotonergic system in burnout has also 
been indicated [136]. 
  Fibromyalgia is characterized by wide spread pain and 
muscle tenderness, as determined by palpation, lasting at 
least three months [8]. In patients with fibromyalgia, a sig-
nificant delay in the rate of decline of cortisol levels from 
acrophase to nadir was reported [137]. A serotonin and nore-
pinephrine reuptake inhibitor was used to successfully treat 
patients with fibromyalgia [138], whereas melatonin was 
also able to reduce the pain associated with this syndrome 
[139]. Physical activity is also known to show favorable ef-
fects on fibromyalgia [140], suggesting involvement of the 
serotonergic system.  
  Decreased circadian rhythm amplitude has been reported 
in the more common conditions of mood disorders, including 
major depressive disorder [141-143], for which serotonin 
reuptake inhibitors are used as antidepressant treatment. Fur-
thermore, a melatonin receptor agonist was shown to exhibit 
a favorable effect on depression [104]. 
  From a therapeutic point of view, decreased serotonergic 
and melatonergic activity is suggested in CFS, burnout,   
fibromyalgia, and depression, although each of these condi-
tions possesses its own specific origin, major symptoms, 
course, and age of onset. 
4. REQUIREMENT FOR A NOVEL CLINICAL   
ENTITY  
  Although delayed wake-up times and bedtimes could be 
symptoms of a delayed sleep phase form of a circadian 
rhythm sleep disorder, it should be noted that the biological- 
and lifestyle-related sleep phase delays that are especially 
common during adolescence are often misdiagnosed as this 
disorder [144]. According to the diagnostic criteria, patients 
with circadian sleep disorders of delayed sleep phase type or 
irregular sleep-wakefulness type should exhibit normal sleep 
duration for their age [8]. But the sleep duration of many of 
the young people in Japan who exhibit intractable circadian 
rhythm disruptions is essentially decreased (or varies day by 
day), and results in complaints of both insomnia and hyper-
somnia. Similarly, sleep insufficiency on weekdays was em-
phasized in Chinese adolescents [4]. In Taiwan, increased 
academic workloads are thought to lead to a delayed bedtime 
and short nocturnal sleep duration among adolescents [145]. 
These adolescents were not diagnosed with circadian rhythm 
sleep disorder of delayed sleep phase type, but the need for 
education on adequate sleep hygiene was emphasized [145]. 
Many adolescents are suffering from disturbed circadian 
rhythms with decreased sleep duration. These young people 
are hard to diagnose as having various types of circadian 
sleep disorders on the basis of diagnostic criteria [8]. An-
other issue of note is that the risks for behavioral and meta-
bolic aspects of these sleep disorders have been increased, 
despite wide recognition of the need for education on sleep 
hygiene [146]. It is possible that certain unknown factors 
other than simple sleep loss and inadequate sleep hygiene are 
involved in many of these problematic adolescents.  
  In 1970, Winfree reported that a specific, dim, blue-light 
pulse stimulus, with a unique stimulus time and duration, 
resulted in unusual broadening of the daily eclosion peaks of 
the fruit fly, Drosophila pseudoobscura, even to the extreme 
of obscuring circadian rhythm [10]. This phenomenon, sup-
pression of circadian rhythms, was called ‘circadian singu-
larity behavior’ [147], and has since been described in a 
range of organisms including algae, plants, and mammals 
[147, 148]. In humans, circadian rhythms of rectal tempera-
ture and plasma cortisol were reported to be abolished by a 
single, long-duration bright-light pulse administered during 
one or two successive circadian cycles [148]. A temperature 
increase and light pulses were shown to trigger circadian 
singularity behavior in Neurospora  circadian clock gene 
frequency [147], whereas a critical light pulse (three-hour 
light pulses delivered at near subjective midnight) was 
shown to drive cellular clocks to singularity behavior in 
mammals [68]. Interestingly, this phenomenon is transient 
[147], although removal of the stimulus is required. These 
findings taken together with the basic entity of singularity 
designated a clinical concept termed ‘asynchronization’. The 
aim of this designation essentially was to explain the afore-
mentioned disturbed conditions of adolescents, assuming that 
the function of the circadian clock of these young people is 
markedly impaired and might be lost.  
5. ASYNCHRONIZATION 
  Asynchronization is the result of disturbed aspects (e.g., 
cycle, amplitude, phase, and interrelationship) of biological 
rhythms that normally exhibit circadian oscillation, which 
presumably involve decreased serotonergic and/or melaton-
ergic activity. The major trigger of asynchronization is con-
sidered to be a combination of light exposure during night-
time, which reduces melatonin secretion, and a lack of morn-
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Both triggers are known to disturb the biological clock in the 
SCN [66]. Asynchronization symptoms (Table 3) include 
disturbances of the autonomic nervous system (sleepiness, 
insomnia, disturbed hormonal secretion, gastrointestinal 
problems, and sympathetic nervous system predominance), 
as well as disturbances of higher brain functions (disorienta-
tion, loss of sociability, loss of will or motivation, and im-
paired alertness and performance). Neurological (attention 
deficits, aggression, impulsiveness, and hyperactivity), psy-
chiatric (depressive disorders, personality disorders, and 
anxiety disorders), and somatic (tiredness, fatigue, neck 
and/or back stiffness, and headache) disturbances are also 
putative symptoms of asynchronization. 
  Among disturbances of the autonomic nervous system, 
asynchronization, over-activation of the sympathetic nervous 
system [149, 150] and disturbed hormonal secretion due to 
activation of the hypothalamic-pituitary-adrenal axis [151, 
152] have been reported in the hyperarousal model of pri-
mary insomnia. Asynchronization and primary insomnia 
might share a common pathophysiological background. It is 
likely that activation of the hypothalamic-pituitary-adrenal 
axis is involved in asynchronization. Irregular bowel habits 
are one of the representative gastrointestinal symptoms of 
asynchronization. Among healthy adults, an increase of 
colonic pressure resulting in emptying of the colon is ob-
served in the morning and during the two hours after meals 
[153], with those with regular bowel habits more likely to 
defecate in the morning [154]. Seventy-seven percent of the 
adult non-patient population in Beijing, for instance, was 
reported to defecate in the morning [155]. Bowel habits are 
under circadian control, and in normal circadian oscillation, 
defecation is expected to be seen regularly in the morning. 
Bowel habits are likely to be easily affected with circadian 
disruptions. Indeed, irritable bowel syndrome (IBS) and CFS 
are reported to share predisposing risks, suggesting a com-
mon predisposing pathophysiology [156]. Similarly, frequent 
overlapping of IBS with conditions showing circadian dis-
ruption (i.e., CFS and fibromyalgia) has been known and the 
question of a common underlying pathophysiology has been 
raised [157].  
Table 3.  Features of Asynchronization 
 Concepts  Details 
Essence  Disturbance of various aspects of biological rhythms 
(e.g., cycle, amplitude, phase, and interrelationship) 
that indicate circadian oscillation 
Presumable causes  Light exposure during the night   
  Lack of light exposure in the morning   
  Decreased physical activity   
Disturbance of biological clock and/or serotonergic/ 
melatonergic systems 
Symptoms  Disturbances related to the autonomic nervous  
system 
Sleepiness, insomnia, disturbance of hormonal secretion, gastrointestinal 
problems, sympathetic nervous system predominance 
 Somatic  disturbances  Tiredness, fatigue, neck and/or back stiffness, headache, persistent 
yawn, desire for sleep, wish to lie down, inactivity, lumbago 
  Disturbances related to higher brain function  Disorientation, loss of sociality, loss of will or motivation, impaired 
alertness and performance, difficulty with memory or concentration 
 Neurological  disturbances  Attention deficit, aggression, impulsiveness, hyperactivity,  
irritation, hypersensitive 
 Psychiatric  disturbances  Symptoms observed in depressive disorders, personality  
disorders, and anxiety disorders 
Therapeutic approaches  Morning light exposure   
  Avoidance of nocturnal light exposure   
 Conventional  approaches  Light therapy, medications (hypnotics, antidepressants, melatonin, 
etc.), physical activation, chronotherapy 
Alternative approaches  Traditional Chinese medicine, qigong, tanden breathing, acupuncture 
Prognosis  Early phase (functional?)  Can be easy to resolve 
  Chronic phase   Difficult to resolve 336 Current Neuropharmacology, 2011, Vol. 9, No. 2 Jun Kohyama 
  The early phase of asynchronization or the state of cir-
cadian desynchronization is easily induced by the described 
disturbances in daily habits, producing unsatisfactory physi-
cal, mental, and/or emotional conditions, presumably leading 
to decreased physical activity. This condition is considered 
to be functional and can be resolved relatively easily by   
establishing a regular sleep-wakefulness cycle. However, 
without adequate intervention, the disturbances can gradually 
worsen, resulting in a further decrease in physical activity 
and also in serotonergic and/or melatonergic activity, which 
can be difficult to resolve (Fig. 1). Patients in the chronic 
phase of asynchronization present daily sleep durations of 
more than 10 hours three times or more in a week, despite 
elevation of sympathetic nervous system activity. Regulation 
of both wake- and sleep-promoting systems might be   
disturbed in the chronic phase of asynchronization.  
  Development of the clinical phases of asynchronization 
might be depend on individual differences not only in the 
ease of rhythm synchronization to the night-day cycle [84] 
but also in the endogeneous period of the circadian clock 
[65]. In addition, certain unknown factors (broad red line) 
might act as promoters of development of the chronic phase 
of asynchronization (Fig. 1). So far, neither preschoolers nor 
adults who have developed the chronic phase of asynchroni-
zation have been reported. Thus, age of adolescence might 
be one of the promoting factors. 
  Pain is a common symptom in depression, fatigue, and 
circadian disruption with or without insomnia/hypersomnia 
[158] as well as in asynchronization, although the underlying 
cause of the pain remains to be determined. Pain is one of the 
diagnostic criteria for childhood CFS [159]; furthermore, a 
relationship between burnout and musculoskeletal pain [160] 
and a 30-60% co-occurrence rate of depression and pain 
[161] have been reported. Regarding these associations, 
Maletic and Raison [158] emphasized the role of dysregula-
tion of stress/inflammatory pathways. In that study, this 
functional change was suggested to promote alterations in 
brain circuitry that modulates mood, pain, and the stress re-
sponse, resulting in disruptions in neurotrophic support and 
disturbances of glia-neuronal communication, especially 
when patients were inadequately treated. This presumable 
situation could also be involved in the chronic phase of 
asynchronization.  
6. POTENTIAL THERAPEUTIC APPROACHES FOR 
ASYNCHRONIZATION 
6.1. Basic Principles 
  For synchronization of the biological clock to a 24-hour 
cycle, exposure to morning light and avoidance of nocturnal 
light are essential. Therefore, failure to practice these two 
behaviors will be risk factors to develop asynchronization. 
Moreover, light-induced adrenal gene expression and corti-
costerone release have been demonstrated [162]. Under nor-
mal conditions, steroid secretion is greatest in the morning. 
As described earlier in this article, physical activity [69], 
social factors [70], and eating time [71] are known to affect 
the circadian clock. Adequate physical activity (exercise), 
participation in social activities, and regular mealtimes are 
likely to prevent asynchronization. A daytime nap is known 
to result in favorable performance [163]. However, evening-
type adolescents were reported to nap more frequently dur-
ing school days than other chronotypes [52], although im-
proved school performance after an afternoon 15-minute nap 
was reported in a Japanese high school [164]. Further studies 
are required to determine whether napping affects asynchro-
nization. Overall, for prevention of asynchronization, social 
promotion of favorable sleep hygiene including health edu-
cation beginning in early elementary school age is important 
[165, 166].  
  Decrease of serotonergic and/or melatonergic activity is 
considered essential pathophysiology of the chronic phase of 
asynchronization (Fig. 1). Interestingly, selective serotonin 
Fig. (1). Schematic drawing of the development of asynchronization. The broad blue lines constitute vicious circles, and enhancement 
of these circles is involved in entering into the chronic phase of asynchronization. Certain unknown factors (broad red line) might act as 
promoters for progression from the early phase into the chronic phase of asynchronization. 
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reuptake inhibitor (fluvoxamine) and selective noradrenalin-
serotonin reuptake inhibitor (desipramine) increased evening 
plasma melatonin concentrations and prolonged the duration 
of elevated melatonin secretion, respectively [167]. De-
sipramine, but not fluvoxamine, increased urinary 6SM ex-
cretion. It is suggested that the elevated plasma melatonin 
observed following fluvoxamine is caused by inhibition of 
CYP1A2-mediated melatonin metabolism [167]. The un-
known common pathway in which both serotonergic systems 
and melatonergic systems are involved might be implicated 
in the chronic phase of asynchronization.  
6.2. Conventional and Alternative Approaches  
  Melatonergic [100, 104, 131, 139] and serotonergic [104, 
130, 138, 143] agents as well as hypnotics, antidepressants, 
vitamin B12, physical activity [140], chronotherapy, and 
bright light in the morning or during the daytime [168] and 
darkness during nighttime [169] are conventional approaches 
used to treat asynchronization. Low dose sulpiride, known to 
exert antidepressant activity through the blockade of D2/D3 
receptors [170], might be another promising choice for the 
treatment.  
  Potential alternative approaches include traditional Chi-
nese medicine, direct contact to the body (e.g.; hug), auto-
nomic nervous system control, pulse light therapy, and 
rhythmic movements such as qigong, tanden breathing, and 
locomotion [3].  
  In addition, favorable effects of acupuncture for depres-
sion [171, 172], fibromyalgia [173], insomnia [174], and 
CFS [175], and of shiatsu (acupressure) for sleep disturbance 
[176] and CFS [177] were reported. These may also be 
promising therapeutic tools for the treatment of asynchroni-
zation. However, their diagnostic standards and methodology 
as treatment strategies remain to be determined. 
7. CONCLUSION 
  This review introduced the clinical notion of asynchroni-
zation, focusing on the association between nocturnal life-
style and biological clock disorders, as well as on the mela-
tonergic and serotonergic systems. There is also potential for 
the involvement of dopamine [170, 178], neuropeptide Y 
[107], and opioid peptides [125] in the pathogenesis of asyn-
chronization.  
  Famous traditional wisdoms [179, 180] also recommend 
morning-type behaviors to have healthy lives. In 1879, Tho-
mas Alva Edison developed a long-lasting, practical electric 
light bulb. At that time, people were wondering whether hu-
man beings could be awake 24 hours a day. Unfortunately, 
the current social trend of 24/7 activity may produce unfa-
vorable effects on the SCN, given that the negative effects of 
exposure to nocturnal light on human beings are well estab-
lished [1, 66-68, 89]. Future studies are required on the de-
tailed properties of the biological clock, with the aim of iden-
tifying treatments for patients suffering from circadian dis-
ruptions.  
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